James Campbell

6.4k total citations
61 papers, 3.3k citations indexed

About

James Campbell is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, James Campbell has authored 61 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 20 papers in Oncology and 7 papers in Physiology. Recurrent topics in James Campbell's work include PARP inhibition in cancer therapy (8 papers), Advanced Proteomics Techniques and Applications (7 papers) and CRISPR and Genetic Engineering (6 papers). James Campbell is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), Advanced Proteomics Techniques and Applications (7 papers) and CRISPR and Genetic Engineering (6 papers). James Campbell collaborates with scholars based in United Kingdom, United States and Ireland. James Campbell's co-authors include Christopher J. Lord, Alan Ashworth, Kerry Fenwick, Iwanka Kozarewa, Rachel Brough, Ioannis Assiotis, Lina Chen, Asha Konde, Florent Elefteriou and Julie A. Sterling and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

James Campbell

59 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Campbell United Kingdom 29 2.1k 1.2k 453 374 313 61 3.3k
Hannu Haapasalo Finland 39 2.4k 1.2× 854 0.7× 431 1.0× 754 2.0× 483 1.5× 131 4.9k
Hermes Garbán United States 32 1.6k 0.8× 672 0.5× 463 1.0× 533 1.4× 251 0.8× 56 3.7k
Xiao‐Nan Li United States 34 2.0k 1.0× 813 0.7× 197 0.4× 601 1.6× 251 0.8× 169 3.7k
Christopher M. Hovens Australia 38 1.8k 0.9× 550 0.4× 361 0.8× 593 1.6× 852 2.7× 121 3.9k
Jie Liu China 32 1.4k 0.7× 1.1k 0.9× 206 0.5× 420 1.1× 381 1.2× 183 3.2k
John Brognard United States 25 3.7k 1.8× 1.0k 0.8× 197 0.4× 658 1.8× 464 1.5× 50 4.5k
Li Cai China 32 1.7k 0.8× 807 0.6× 338 0.7× 802 2.1× 524 1.7× 159 3.3k
Vanessa Almendro Spain 29 2.3k 1.1× 1.4k 1.1× 730 1.6× 1.5k 4.0× 509 1.6× 53 4.6k
Jun Wei China 31 1.8k 0.9× 501 0.4× 231 0.5× 248 0.7× 241 0.8× 169 3.6k
James G. Jackson United States 36 2.4k 1.2× 1.5k 1.2× 511 1.1× 818 2.2× 250 0.8× 70 3.8k

Countries citing papers authored by James Campbell

Since Specialization
Citations

This map shows the geographic impact of James Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Campbell more than expected).

Fields of papers citing papers by James Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Campbell. The network helps show where James Campbell may publish in the future.

Co-authorship network of co-authors of James Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of James Campbell. A scholar is included among the top collaborators of James Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Campbell. James Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
George, Sally L., Federica Lorenzi, David S. King, et al.. (2020). Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma. EBioMedicine. 59. 102971–102971. 47 indexed citations
2.
Naidoo, Kuban D., Patty T. Wai, Sarah Maguire, et al.. (2018). Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer. Molecular Cancer Therapeutics. 17(1). 306–315. 54 indexed citations
3.
Chong, Irene, Lauren I. Aronson, Aditi Gulati, et al.. (2017). Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer. Gut. 67(10). 1780–1792. 16 indexed citations
4.
Dréan, Amy, Chris T. Williamson, Rachel Brough, et al.. (2017). Modeling Therapy Resistance in BRCA1/2 -Mutant Cancers. Molecular Cancer Therapeutics. 16(9). 2022–2034. 58 indexed citations
5.
Ashenden, Matthew, Antoinette van Weverwijk, Nirupa Murugaesu, et al.. (2017). An In Vivo Functional Screen Identifies JNK Signaling As a Modulator of Chemotherapeutic Response in Breast Cancer. Molecular Cancer Therapeutics. 16(9). 1967–1978. 18 indexed citations
6.
Jones, Samuel E., Emmy D.G. Fleuren, Jessica Frankum, et al.. (2017). ATR Is a Therapeutic Target in Synovial Sarcoma. Cancer Research. 77(24). 7014–7026. 47 indexed citations
7.
Campbell, James, Mingzong Li, Li Yu, et al.. (2016). Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 15(11). 2598–2608. 47 indexed citations
8.
Costa-Cabral, Sara, Rachel Brough, Asha Konde, et al.. (2016). CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours. PLoS ONE. 11(2). e0149099–e0149099. 58 indexed citations
9.
Maguire, Sarah, Barrie Peck, Patty T. Wai, et al.. (2016). Three‐dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model. The Journal of Pathology. 240(3). 315–328. 31 indexed citations
10.
Francis, Jeffrey C., Lorenzo Melchor, James Campbell, et al.. (2015). Whole‐exome DNA sequence analysis of Brca2‐ and Trp53‐deficient mouse mammary gland tumours. The Journal of Pathology. 236(2). 186–200. 11 indexed citations
11.
Malki, Karim, Yann S. Mineur, Maria Grazia Tosto, et al.. (2015). Pervasive and opposing effects of Unpredictable Chronic Mild Stress (UCMS) on hippocampal gene expression in BALB/cJ and C57BL/6J mouse strains. BMC Genomics. 16(1). 262–262. 29 indexed citations
12.
Chong, Irene, David Cunningham, James Campbell, et al.. (2014). Druggable Genetic Dependencies for Molecularly Defined Subgroups of Oesophageal Cancer Identified From High-Throughput Functional Profiling. Annals of Oncology. 25. ii11–ii11.
13.
Herrera-Abreu, María Teresa, Alex Pearson, James Campbell, et al.. (2013). Parallel RNA Interference Screens Identify EGFR Activation as an Escape Mechanism in FGFR3 -Mutant Cancer. Cancer Discovery. 3(9). 1058–1071. 98 indexed citations
14.
Bajrami, Ilirjana, Jessica Frankum, Asha Konde, et al.. (2013). Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity. Cancer Research. 74(1). 287–297. 279 indexed citations
15.
García-Murillas, Isaac, Rachel Sharpe, Alex Pearson, et al.. (2013). An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer. Oncogene. 33(19). 2478–2486. 28 indexed citations
16.
Cassat, James E., Neal D. Hammer, James Campbell, et al.. (2013). A Secreted Bacterial Protease Tailors the Staphylococcus aureus Virulence Repertoire to Modulate Bone Remodeling during Osteomyelitis. Cell Host & Microbe. 13(6). 759–772. 184 indexed citations
17.
Campbell, James, et al.. (2012). Models of Bone Metastasis. Journal of Visualized Experiments. e4260–e4260. 89 indexed citations
18.
Leung, Kit‐Yi, Pierre Lescuyer, James Campbell, et al.. (2005). A novel strategy using MASCOT Distiller for analysis of cleavable isotope‐coded affinity tag data to quantify protein changes in plasma. PROTEOMICS. 5(12). 3040–3044. 9 indexed citations
19.
Kennedy, Andrew, et al.. (2001). The OMENS trial: opportunistic evaluation of musculo-skeletal physician care among orthopaedic outpatients unlikely to require surgery.. PubMed. 59(3). 198–210. 8 indexed citations
20.
Pritchard, Kathleen I., et al.. (1981). The Role of Tamoxifen in Premenopausal Women with Metastatic Carcinoma of the Breast - An Update. Queensland's institutional digital repository (The University of Queensland). 22. 436–436. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannu Haapasalo Breakdown of academic impact, for papers by Hermes Garbán Breakdown of academic impact, for papers by Xiao‐Nan Li Breakdown of academic impact, for papers by Christopher M. Hovens Breakdown of academic impact, for papers by Jie Liu Breakdown of academic impact, for papers by John Brognard Breakdown of academic impact, for papers by Li Cai Breakdown of academic impact, for papers by Vanessa Almendro Breakdown of academic impact, for papers by Jun Wei Breakdown of academic impact, for papers by James G. Jackson
Rankless by CCL
2026